In colon cancer, knocking down LASS6 leads to a specific decrease in C16 neuramides, which protects tumor cells from TRAIL-mediated apoptosis and interferes with the entry of active Caspase-3 into the nucleus [52]. Here, CERS6 is linked to neoplasm.